News
Human Rights Campaign und Bloomberg würdigen QIAGENs Engagement im Bereich LGBTQ+- und Geschlechtergleichstellung
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass das Engagement des Unternehmens für mehr Vielfalt und Gleichstellung von Geschlechtern am Arbeitsplatz durch die
QIAGEN’s Commitment to LGBTQ+ and Gender Equality Recognized by Human Rights Campaign and Bloomberg Indexes
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its commitment to workplace diversity and gender equality has been recognized by inclusion in the U.S. LGBTQ+ Corporate
Gerresheimer AG: Der führende Anbieter von Injektionsfläschchen Gerresheimer erweitert Produktion in Wertheim
Gerresheimer AG: The leading supplier of injection vials Gerresheimer expands production in Wertheim
Charles River Expands Strategic Partnership With SAMDI Tech
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of their strategic partnership with Chicago, Illinois-based SAMDI Tech, Inc. Under the existing partnership
AMN Healthcare Commitment Supports Underserved Nurses and Nurse Wellness
In line with its commitment to the health and wellbeing of nurses, and for advancing diversity, equality, equity, and inclusion in the nursing profession, AMN Healthcare is donating to support the
QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has completed a U.S. government contract to equip public health laboratories across the country with the QIAcuity digital
QIAGEN rüstet im Auftrag von US-Bundesbehörde lokale Gesundheitslabore mit digitalem PCR-System QIAcuity für die COVID-19 Überwachung aus
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, im Rahmen der Erfüllung eines mit der US-Regierung geschlossenen Vertrags das digitale PCR-System QIAcuity landesweit an
DGAP-News: Evotec geht iPSC-basierte Forschungspartnerschaft mit Boehringer Ingelheim im Bereich Augenheilkunde ein
DGAP-News: Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology
DGAP-News: Frauenanteil in Führungspositionen: MorphoSys Nummer 1 in Deutschland im European Women on Boards Gender Equality Index Report
DGAP-News: MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards' Gender Equality Index Report
AMN Healthcare to Hold Fourth Quarter and Full Year 2021 Earnings Conference Call on Thursday, February 17, 2022
AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and full year 2021 financial results and first quarter 2022 outlook on Thursday, February
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.20 per share of Class A common
Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2021 financial results on Wednesday, February 16th, before the market opens. A conference call
Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
Charles River Laboratories International, Inc. (NYSE: CRL) and Valo Health, LLC (“Valo”), the technology company using human-centric data and computation powered by artificial intelligence (AI) to
QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced today that it plans to release its report on results for the fourth quarter and full-year results of 2021 on Tuesday, February 8
VFMCRP receives EU approval for Tavneos® for the treatment of ANCA-associated vasculitis
Regulatory News:
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that the European Commission has approved Tavneos® in combination with a rituximab or cyclophosphamide regimen
QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its new QIAwave product line by launching three nucleic acid extraction kits that use fewer components and produce less waste
QIAGEN führt mit QIAwave umweltfreundliche Produktlinie ein
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Einführung seiner neuen Produktlinie QIAwave und der ersten drei QIAwave Nukleinsäure-Extraktionskits bekannt. Diese neuen Kits
PINC AI™ Launches INsights, an Enhanced Technology Offering for Customized, On-Demand Healthcare Analytics
PINC AI™, the technology and services platform of Premier, Inc (NASDAQ: PINC), today launched INsights, an enhanced self-service healthcare solution for the creation of customized, on-demand
CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd.
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220117005418/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
CSL
DGAP-News: Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
DGAP-News: Evotec und Lilly gehen Zusammenarbeit zur Erforschung von Wirkstoffen im Bereich Stoffwechselerkrankungen ein
DGAP-Adhoc: RHÖN-KLINIKUM AG has reached an agreement with the State of Hesse on letter of intent on public investment subsidies